The decision may have been made to avoid regulation by the FDA, according to BuzzFeed.
"Advanced biotracking sensors would have made the Apple Watch less of a multipurpose consumer device and more of a medical device used to diagnose diseases or track chronic conditions — which could have opened the watch up to regulation by the U.S. Food and Drug Administration.
'I don’t think Apple wants to be a health-monitoring device maker,' said Harry Wang, director of health and mobile product research at Parks Associates. 'They do want to leverage their popularity on the iPhone as a device platform, integrating all health data that can be collected for different devices.'"
From the article "The Apple Watch Is Scaling Back Its Health Features" by Ian Servantes.
Parks Associates research finds that the percentage of households with multiple OTT subscriptions has increased by 130% since 2014. In 2019, forty-six percent of US broadband households subscribe to t...
Global energy market research and consulting firm Parks and Associates issued a whitepaper analysing the global market for the Internet of Things (IoT). The whitepaper Top 10 Consumer IoT Trends in...
People are twice more likely to buy individual smart locks, doorbells and security cameras than sign up for a professional home monitoring service. That's the findings of a new report from security re...
As Amazon launches its standalone Music Unlimited streaming service, research firm Parks Associates has been reminding the industry of the popularity of the company’s existing Prime Music offering, ba...
